Analyst Downgrades: Bed Bath & Beyond Inc., Valeant Pharmaceuticals Intl Inc, and Tesla Motors Inc

Analysts downwardly revised their ratings and price targets on Bed Bath & Beyond Inc. (NASDAQ:BBBY), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and Tesla Motors Inc (NASDAQ:TSLA)

by Josh Selway

Published on Jun 23, 2016 at 9:06 AM

Analysts are weighing in on home goods retailer Bed Bath & Beyond Inc. (NASDAQ:BBBY), biotech stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and automaker Tesla Motors Inc (NASDAQ:TSLA). Here's a quick roundup of today's bearish brokerage notes on BBBY, VRX, and TSLA.

  • BBBY is down almost 4% in pre-market trading, following the company's disappointing first-quarter earnings release. This was met with a round of bearish analyst attention, including price-target cuts from no fewer than eight brokerage firms. Among the bunch was Credit Suisse, setting the lowest mark at $41. Bearish analyst attention is nothing new for Bed Bath & Beyond Inc., though. Just one of the 16 analysts providing coverage on the stock recommends buying it. And it's no wonder, considering BBBY has fallen almost 39% in the past 12 months, to trade at $43.18. 

  • VRX is edging 1.1% higher ahead of the open, despite a downgrade to "neutral" from "overweight" at J.P. Morgan Securities, which also cut its price target to $35 from $50. The stock closed Wednesday at $21.64, rebounding slightly after hitting fresh multi-year lows earlier this week. Despite its technical struggles, Valeant Pharmaceuticals Intl Inc bulls can still be found on Wall Street and in the options pits. For instance, five analysts still consider the stock a "strong buy," while VRX's Schaeffer's put/call open interest ratio (SOIR) of 0.63 marks a 12-month call-skewed low. 
  • TSLA looks poised to continue Wednesday's sell-off, as analysts turn bearish following the company's "no brainer" M&A announcement. Just this morning, Morgan Stanley downgraded the stock to "equal weight," while Berenberg lowered its price target to $145 from $150. While this is far below Tesla Motors Inc's Wednesday settlement at $196.66, the stock was trading below $145 as recently as February. Another day in the red could put TSLA in oversold territory, with the stock's 14-day Relative Strength Index (RSI) registering at 31 as of yesterday's close -- right above the oversold threshold. 
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Google Postpones Android Reveal, "Now is Not the Time to Celebrate"
"Now is not the time to celebrate," Google said in a message on its website
ZNGA Zooms to 8-Year High on Billion-Dollar Deal
ZNGA is planning to buy Peak for $1.8 billion
Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....